Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET
Authors
Keywords
-
Journal
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume -, Issue -, Pages 0271678X2110189
Publisher
SAGE Publications
Online
2021-05-30
DOI
10.1177/0271678x211018904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel tau filament fold in corticobasal degeneration
- (2020) Wenjuan Zhang et al. NATURE
- Early-phase [18F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
- (2020) Leonie Beyer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
- (2020) Adam S. Fleisher et al. JAMA Neurology
- Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases
- (2020) Elizabeth C. Mormino et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
- (2020) Matthias Brendel et al. JAMA Neurology
- Tau PET imaging in neurodegenerative tauopathies—still a challenge
- (2019) Antoine Leuzy et al. MOLECULAR PSYCHIATRY
- The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?
- (2019) Yann Fichou et al. Acta Neuropathologica Communications
- Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
- (2019) Yi Ting Wang et al. Current Neurology and Neuroscience Reports
- Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
- (2019) Heiko Kroth et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Four-repeat tauopathies
- (2019) Thomas W. Rösler et al. PROGRESS IN NEUROBIOLOGY
- Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome
- (2019) Nobutaka Sakae et al. Alzheimers & Dementia
- Tau PET imaging with 18F-PI-2620 in patients with Alzheimer's disease and healthy controls: a first-in-human study
- (2019) Andre Mueller et al. JOURNAL OF NUCLEAR MEDICINE
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- In vivo18F-AV-1451 tau PET signal inMAPTmutation carriers varies by expected tau isoforms
- (2018) David T. Jones et al. NEUROLOGY
- [18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy
- (2018) Matthias Brendel et al. Frontiers in Aging Neuroscience
- Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy
- (2018) Aiko Ishiki et al. Acta Neuropathologica Communications
- Spreading of Amyloid, Tau, and Microvascular Pathology in Alzheimer's Disease: Findings from Neuropathological and Neuroimaging Studies
- (2018) Dietmar Rudolf Thal et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers for tau pathology
- (2018) Michael Schöll et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
- (2017) Francis T. Hane et al. JOURNAL OF ALZHEIMERS DISEASE
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
- (2017) Günter U. Höglinger et al. MOVEMENT DISORDERS
- Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
- (2017) Laetitia Lemoine et al. Alzheimers Research & Therapy
- Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
- (2017) Kok Pin Ng et al. Alzheimers Research & Therapy
- Positron emission tomography imaging of tau pathology in progressive supranuclear palsy
- (2016) Sarah Coakeley et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Reference Tissue–Based Kinetic Evaluation of 18 F-AV-1451 for Tau Imaging
- (2016) Suzanne L. Baker et al. JOURNAL OF NUCLEAR MEDICINE
- Modeling Strategies for Quantification of In Vivo 18 F-AV-1451 Binding in Patients with Tau Pathology
- (2016) Andreas Hahn et al. JOURNAL OF NUCLEAR MEDICINE
- Kinetic Modeling of the Tau PET Tracer 18 F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects
- (2016) Olivier Barret et al. JOURNAL OF NUCLEAR MEDICINE
- Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease
- (2016) S. Shcherbinin et al. JOURNAL OF NUCLEAR MEDICINE
- PET Imaging of Tau Deposition in the Aging Human Brain
- (2016) Michael Schöll et al. NEURON
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau
- (2015) Sayuri Taniguchi-Watanabe et al. ACTA NEUROPATHOLOGICA
- The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015
- (2015) William J. Jagust et al. Alzheimers & Dementia
- Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
- (2015) Marta Marquié et al. ANNALS OF NEUROLOGY
- Tau positron emission tomographic imaging in aging and early Alzheimer disease
- (2015) Keith A. Johnson et al. ANNALS OF NEUROLOGY
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
- (2015) R. Harada et al. JOURNAL OF NUCLEAR MEDICINE
- Tau and neurodegenerative disease: the story so far
- (2015) Khalid Iqbal et al. Nature Reviews Neurology
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Corticobasal Degeneration
- (2014) Ana Grijalvo-Perez et al. SEMINARS IN NEUROLOGY
- Differentiation of Progressive Supranuclear Palsy: clinical, imaging and laboratory tools
- (2013) R. M. Liscic et al. ACTA NEUROLOGICA SCANDINAVICA
- Tau pathology and neurodegeneration
- (2013) Maria Grazia Spillantini et al. LANCET NEUROLOGY
- Criteria for the diagnosis of corticobasal degeneration
- (2013) M. J. Armstrong et al. NEUROLOGY
- Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
- (2013) Masahiro Maruyama et al. NEURON
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Does corticobasal degeneration exist? A clinicopathological re-evaluation
- (2010) H. Ling et al. BRAIN
- Tau in Alzheimer Disease and Related Tauopathies
- (2010) K. Iqbal et al. Current Alzheimer Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started